FDA Approves Twice-Yearly Injectable to Prevent HIV
The FDA has approved a first ever twice-yearly injectable regimen for HIV prevention in adults and adolescents, offering an effective alternative to daily PrEP.
NYC's buildings are on the climate clock. Urban Green Council breaks down lobby letter grades, Local Law 97, smart tech and the city's race to net zero.
Kory Kantenga, Head of Economics, Americas at LinkedIn, breaks down hiring trends, labor-market resilience and where employers are still seeking workers.
Vanessa Hudgens and Oliver Trevena, co-founders of Caliwater, reveal why they’re betting on cactus water, the rise of healthy beverages and plans to grow bigger
Adam Turnquist, Chief Cross-Asset Strategist at LPL Financial, breaks down why stocks remain near records despite higher oil prices, rates and Fed tightening.